An observational study in Ventricular Tachycardia, End-stage Heart Failure and Ventricular Arrythmia, sponsored by Universitätsklinikum Köln. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-03.
Sponsored by Universitätsklinikum Köln · Observational
The CHANNELED-Registry is a multicenter retrospective study to (1) systematically assess the mechanism and origin of ventricular tachycardia in patients with end-stage heart failure carrying an left ventricular assist device (LVAD) and (2) to evaluate procedural parameters and outcome of ventricular tachycardia ablation in this special subset of patients.
451 studies on the registry are indexed under Tachycardia, Ventricular; 120 are open to participants now.
This study's planned enrollment of 50 is below the median of 167 across 147 observational studies indexed under Tachycardia, Ventricular.
Browse Tachycardia, Ventricular studies →Universitätsklinikum Köln is the lead sponsor of 33 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients with end-stage heart failure and an implanted LVAD which underwent ablation of ventricular tachycardia will be included in this retrospective observational study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with end-stage heart failure with an LVAD implanted undergoing VT ablation.
Other: Ablation
VT ablation
Mechanism of ventricular tachycardia in LVAD patients (descriptive name of scale)
Assessment of the mechanism of VT in LVAD patients (e.g LVAD cannula related vs. related to substrate of underlying heart disease)
Time frame: 12 month
Number of patients with ventricular tachycardia recurrence in device interrogation (physiological parameter)
Assessment of VT recurrence after ablation: Device interrogation and readout of ICD Holter
Time frame: 12 month
Mortality (physiological parameter)
Assessment of mortality after VT ablation.
Time frame: 12 month
Heart failure Hospitalization (physiological parameter)
Assessment of Hospitalization for worsening of Heart Failure after VT ablation.
Time frame: 12 month
Procedure duration (From groin puncture to sheath removal in minutes)
Evaluation of the duration of VT ablation procedures in LVAD patients
Time frame: 12 month
Fluoroscopy time (minutes)
Evaluation of the fluroscopy use (in minutes)
Time frame: 12 month
Radiofrequency energy used for ablation (in watts; e.g. 40 Watts)
Evaluation of the maximum RF-energy used for ablation
Time frame: 12 month
Number of patients suffering from intraprocedural complication (physiological parameter, e.g. hematoma)
Evaluation of intraprocedural complications of VT ablation
Time frame: 12 month
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2023; primary completion for Jan 2024, 3 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitätsklinikum Köln